Literature DB >> 30788590

The role of MRI for detection and staging of radio- and focal therapy-recurrent prostate cancer.

Henk van der Poel1,2, Nikos Grivas3,4, Pim van Leeuwen3,4, Stijn Heijmink3,4, Ivo Schoots3,4.   

Abstract

Local recurrent prostate cancer after radical treatment is found in the majority of men with a rising PSA. Salvage treatment procedures for recurrent disease, such as radiation therapy and ablative procedures, can provide long-term responses in well-selected cases. Prostate magnetic resonance imaging (MRI) allows diagnosis and staging, and the value provides information on treatment selection, treatment planning and treatment guidance in local recurrent prostate cancer.

Entities:  

Keywords:  Cryotherapy; Focal therapy; HIFU; Prostate cancer; Prostatectomy; Radiorecurrent; Salvage; mpMRI

Mesh：

Year:  2019        PMID： 30788590     DOI： 10.1007/s00345-019-02677-y

Source DB:  PubMed          Journal:  World J Urol        ISSN： 0724-4983            Impact factor:   4.226


  39 in total

1.  Potential Impact of 68Ga-PSMA-11 PET/CT on the Planning of Definitive Radiation Therapy for Prostate Cancer.

Authors:  Jeremie Calais; Amar U Kishan; Minsong Cao; Wolfgang P Fendler; Matthias Eiber; Ken Herrmann; Francesco Ceci; Robert E Reiter; Matthew B Rettig; John V Hegde; Narek Shaverdian; Chris R King; Michael L Steinberg; Johannes Czernin; Nicholas G Nickols
Journal:  J Nucl Med       Date:  2018-04-13       Impact factor: 10.057

2.  Interaction of habit (H) and drive (D) in classical eyelid conditioning. II. H and D as functions of UCS intensity.

Authors:  J J Hug; J J Porter
Journal:  J Exp Psychol       Date:  1968-05

3.  68Ga-PSMA PET/CT in patients with recurrent prostate cancer after radical treatment: prospective results in 314 patients.

Authors:  Paola Caroli; Israel Sandler; Federica Matteucci; Ugo De Giorgi; Licia Uccelli; Monica Celli; Flavia Foca; Domenico Barone; Antonino Romeo; Anna Sarnelli; Giovanni Paganelli
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-06-19       Impact factor: 9.236

4.  Anatomical Patterns of Recurrence Following Biochemical Relapse in the Dose Escalation Era of External Beam Radiotherapy for Prostate Cancer.

Authors:  Zachary S Zumsteg; Daniel E Spratt; Paul B Romesser; Xin Pei; Zhigang Zhang; Marisa Kollmeier; Sean McBride; Yoshiya Yamada; Michael J Zelefsky
Journal:  J Urol       Date:  2015-07-10       Impact factor: 7.450

5.  Detection of recurrent prostate cancer after primary radiation therapy: An evaluation of the role of multiparametric 3T magnetic resonance imaging with endorectal coil.

Authors:  Fabio Zattoni; Akira Kawashima; Alessandro Morlacco; Brian J Davis; Avinash K Nehra; Lance A Mynderse; Adam T Froemming; R Jeffrey Karnes
Journal:  Pract Radiat Oncol       Date:  2016-06-14

6.  Detection of local, regional, and distant recurrence in patients with psa relapse after external-beam radiotherapy using (11)C-choline positron emission tomography.

Authors:  Anthonius J Breeuwsma; Jan Pruim; Alphons C M van den Bergh; Anna M Leliveld; Rien J M Nijman; Rudi A J O Dierckx; Igle J de Jong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-09-23       Impact factor: 7.038

7.  The utility of PET-based imaging for prostate cancer biochemical recurrence: a systematic review and meta-analysis.

Authors:  Niranjan J Sathianathen; Mohit Butaney; Badrinath R Konety
Journal:  World J Urol       Date:  2018-07-12       Impact factor: 4.226

8.  Comparison of 68Ga-HBED-CC PSMA-PET/CT and multiparametric MRI for gross tumour volume detection in patients with primary prostate cancer based on slice by slice comparison with histopathology.

Authors:  Constantinos Zamboglou; Vanessa Drendel; Cordula A Jilg; Hans C Rischke; Teresa I Beck; Wolfgang Schultze-Seemann; Tobias Krauss; Michael Mix; Florian Schiller; Ulrich Wetterauer; Martin Werner; Mathias Langer; Michael Bock; Philipp T Meyer; Anca L Grosu
Journal:  Theranostics       Date:  2017-01-01       Impact factor: 11.556

9.  68Ga PSMA-11 PET with CT urography protocol in the initial staging and biochemical relapse of prostate cancer.

Authors:  Amir Iravani; Michael S Hofman; Tony Mulcahy; Scott Williams; Declan Murphy; Bimal K Parameswaran; Rodney J Hicks
Journal:  Cancer Imaging       Date:  2017-12-21       Impact factor: 3.909

Review 10.  Comparative Oncologic and Toxicity Outcomes of Salvage Radical Prostatectomy Versus Nonsurgical Therapies for Radiorecurrent Prostate Cancer: A Meta-Regression Analysis.

Authors:  Yiannis Philippou; Richard A Parker; Dimitrios Volanis; Vincent J Gnanapragasam
Journal:  Eur Urol Focus       Date:  2015-10-04
View more
  1 in total

1.  Value of Targeted Biopsies and Combined PSMA PET/CT and mp-MRI Imaging in Locally Recurrent Prostate Cancer after Primary Radiotherapy.

Authors:  Marnix Rasing; Marieke van Son; Marinus Moerland; Bart de Keizer; Frank Wessels; Trudy Jonges; Sandrine van de Pol; Wietse Eppinga; Juus Noteboom; Jan Lagendijk; Jochem van der Voort van Zijp; Max Peters
Journal:  Cancers (Basel)       Date:  2022-02-03       Impact factor: 6.639
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.